Loading…
Loading…
See exactly how NUMI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NUMI and 80,000+ other tickers.
This actively managed fund primarily invests in high-quality, long-term municipal bonds, typically maintaining an average maturity exceeding ten years. A substantial team of credit experts diligently searches for value by exploiting inefficiencies within the municipal bond market, aiming to deliver the highest possible level of tax-exempt income and capital growth to investors.
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2026) - Numinus Wellness Inc. (TSX: NUMI) (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with an emphasis on safe, evidence-based psychedelic-assisted therapies, is providing an update regarding its listing status on the Toronto Stock Exchange ("TSX"). As previously disclosed in the Company's management information circular dated July 29, 2025, and as approved by shareholders at the Company's annual general meeting held on August 28, 2025 (with voting results subsequently disclosed on September 3, 2025), shareholders authorized the Board of Directors, in its discretion, to voluntarily delist the Company's common shares from the TSX if deemed to be in the best interests of the Company.
Trifecta of psychedelics healing and wellness solutions Numinus Bioscience is a Health Canada-licensed lab Numinus R&D is developing psychedelic-assisted therapeutic protocols Numinus Health supports practitioners in delivering best-in-class treatments What Numinus Wellness does: Numinus Wellness Inc (CVE:NUMI) (OTCMKTS:LKYSF) (FRA:LR23) is an integrated mental health company creating an ecosystem of health solutions to research, develop, and deliver safe, evidence-based, accessible psychedelic-assisted psychotherapy. The group operates three business lines: Numinus Bioscience is a Health Canada-licensed lab for psychedelic substance research, developing IP while offering analytics services for revenue generation.